SCHEMBL28820380

SCHEMBL28820380

CN(C(=O)OC(C)(C)C)C(CCCCN(Cc1ccccc1)C(=O)O)C(=O)N(Cc1cccs1)Cc1cccs1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ CHRM2 P08172 1/20 0.41
▸ CHRM1 P11229 1/20 0.41
▸ CHRM3 P20309 1/20 0.41
▸ TSHR P16473 2/20 0.40
▸ GAA P10253 1/20 0.39
▸ HTT P42858 2/20 0.38
▸ NPSR1 Q6W5P4 2/20 0.38
▸ HDAC1 Q13547 2/20 0.38
▸ HDAC6 Q9UBN7 1/20 0.38
▸ POLB P06746 2/20 0.38
▸ MAPT P10636 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ ADAM17 P78536 2/20 0.38
▸ USP2 O75604 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ HDAC3 O15379 1/20 0.38
▸ HDAC2 Q92769 1/20 0.38
▸ NCOR2 Q9Y618 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15238983 1.00 ALDH1A1 (0.42) ALDH1A1SMN1; SMN2CHRM2CHRM1CHRM3
SCHEMBL15238932 0.87 ALDH1A1 (0.45) ALDH1A1SMN1; SMN2CHRM2CHRM1CHRM3
SCHEMBL18523322 0.85 RIPK1 (0.39) CHRM2CHRM1CHRM3POLBADAM17
SCHEMBL6122608 0.84 RIPK1 (0.40) ALDH1A1SMN1; SMN2CHRM2CHRM1CHRM3
SCHEMBL16762211 0.83 ADAM17 (0.41) ALDH1A1SMN1; SMN2GAAPOLBADAM17
SCHEMBL29963969 0.83 FOLH1 (0.50) ALDH1A1SMN1; SMN2GAAMAPT
SCHEMBL15238958 0.82 CTSK (0.52) ALDH1A1SMN1; SMN2GAA
SCHEMBL15238991 0.82 CTSK (0.52) ALDH1A1SMN1; SMN2GAA
SCHEMBL15238716 0.79 CTSK (0.52) ALDH1A1SMN1; SMN2GAA
SCHEMBL28820406 0.79 CTSK (0.52) ALDH1A1SMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107820429-B Novel compositions and methods for immunotherapy comprising small molecule integrin receptor-ligand agonist adjuvants 7山药物有限责任公司 2022-08-16 — — CN disclosed
Send feedback